Mednow Inc. Acquires Infusicare Canada Inc.

December 13, 2021

Mednow Inc. (TSXV:MNOW) has completed the acquisition of Infusicare Canada Inc. for C$1.85 million in cash. The specialty pharmacy, which generated C$9.3 million in revenue in its last fiscal year, will be integrated into Mednow’s digital pharmacy platform to expand its specialty and biologic drug offerings.

Buyers
Mednow Inc.
Targets
Infusicare Canada Inc.
Sellers
Amir Ali Reyany-Bozorg, Felipe Campusano
Location
Canada
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.